Navigation Links
Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/10/2009

perational decision making.

Below is a reconciliation of the non-GAAP net loss and loss per basic and diluted share amounts presented in this press release to the GAAP net loss and loss per basic and diluted share amounts presented in this press release (amounts in millions except per share data):

                             Quarter Ended June 30    Six Months Ended June 30
                                2009        2008         2009         2008
    GAAP net loss             $(54.8)     $(24.2)      $(76.8)      $(41.8)
    Impact of change in
      warrant valuation        (35.8)         $-       $(35.8)          $-
    Non-GAAP net loss         $(19.0)     $(24.2)      $(41.0)      $(41.8)



                             Quarter Ended June 30    Six Months Ended June 30
                                2009        2008          2009        2008
    GAAP loss per basic
     and diluted share        $(0.92)     $(0.45)       $(1.35)      $(0.78)
    Impact of change in
      warrant valuation        (0.60)         $-        $(0.63)          $-
    Non-GAAP loss per basic
     and diluted share        $(0.32)     $(0.45)       $(0.72)      $(0.78)

ABOUT SAVIENT PHARMACEUTICALS, INC.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and marketing pharmaceutical products that target unmet medical needs in both niche and broader specialty markets. Savient has developed one product: KRYSTEXXA(TM) (pegloticase) which is a PEGylated uricase enzyme intended for the treatment of chronic gout in patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA, formerly referred to as Puricase((R)) from Duke University and Mountain View Pharmaceuticals, Inc. Savient also manufactures and supplies Oxandrin((R)) (oxandrolone tablets, U
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th
2. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
3. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
4. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
5. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
6. Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... 28, 2015 , ... “ Frequentz ” was featured on NewsWatch as part ... on the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch ... allows businesses to track product movement from beginning to end. , Businesses benefit greatly ...
(Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the nation’s largest travel ... in Healthcare by Modern Healthcare and will be honored at an awards dinner ... year, the Best Places to Work in Healthcare program recognizes outstanding employers in the ...
(Date:8/28/2015)... ... August 28, 2015 , ... Dr. Gregory K. Toumayan, D.C., ... pain resulting in shoulder pain, hip pain, neck pain, stiffness, muscle spasms, ... from the University of Illinois, and then went on to earn his title of ...
(Date:8/28/2015)... ... ... Northridge dentists Dr. Elyson and Dr. Assili are now offering ... receive a one hour treatment of this teeth whitening option. Zoom whitening ... unique features that can turn teeth up to nine shades whiter. Effective on a ...
(Date:8/28/2015)... Ca (PRWEB) , ... August 28, 2015 , ... ... administering medical evaluations for those seeking to go deep sea diving. The ... oxygen toxicity, and decompression sickness; for these reasons, it is vital that all ...
Breaking Medicine News(10 mins):Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Healthpointe Now Offering Scuba Physicals 2
... ,A new study hints at one reason that black Americans are ... Blacks appear to have higher levels of a certain type of ... standard screening. This so-called "non-calcified plaque" -- which consists of ... can rupture and send out blood clots that can lead to ...
... nurses doubt that a clinical neurological examination can establish that ... that this uncertainty can affect relatives when the question of ... the Sahlgrenska Academy, University of Gothenburg, Sweden. End-of-life ... for patients who are brain dead and who by their ...
... weigh less than their non-consuming counterparts, according to a new ... a peer-reviewed journal. This is potentially important ... But lead researcher Carol O,Neil, PhD, MPH, LDN, RD, Louisiana ... put into perspective. "The study illustrates that children ...
... The process of cell division is tightly regulated, as mistakes ... fingered as causing tumors in both skin and liver. ... Medicine, Vienna, has now uncovered a surprising detail with the ... an important anti-tumor factor. The results have recently been ...
... , TUESDAY, June 28 (HealthDay News) -- A flexible work ... their jobs after giving birth, according to a new study. ... flexible schedule provides working moms with alternatives for meeting those ... better able to control their work environment and adapt, work-related ...
... may have discovered one reason that African Americans are at ... According to a new study published online in the ... non-calcified plaque, which consists of buildups of soft deposits deep ... by some cardiac tests. Non-calcified plaque is more vulnerable to ...
Cached Medicine News:Health News:Study Hints at Why Heart Disease Is More Deadly for Blacks 2Health News:Intensive care nurses have doubts about method for establishing brain death 2Health News:Intensive care nurses have doubts about method for establishing brain death 3Health News:New study shows children and adolescents who eat candy are less overweight or obese 2Health News:The good, the bad and the ugly: The many roles of c-JUN in cancer 2Health News:Flexible Schedule Helps Keep New Moms in the Workplace 2Health News:CT angiography improves detection of heart disease in African-Americans 2
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Tobramycin ... Tobramycin is a traditional antibiotic whose eye drop and ... treatment of potential infection or inflammation caused by eye ... are able to produce tobramycin, among which ...
(Date:8/28/2015)... , Aug. 28, 2015 Patterson Medical, ... (Nasdaq: PDCO ), is now an independent ... acquisition of Patterson Medical by Madison Dearborn Partners ... its name for a transition period before rebranding ... and sports medicine products.  With the focused resources ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... to their offering. Developed by Novo ... Novolog) is an important drug for the treatment ... as a fast- acting insulin analog, starts working ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... , MT. LAUREL, N.J., Dec. 1 ... of technology-enabled clinical documentation services, today announced that the radiology ... SpeechQ for Radiology(TM), MedQuist,s real-time speech recognition system. The solution ... (RSNA) convention November 29 through December 2. ...
... , PISCATAWAY, N.J., Dec. 1 Siemens ... hearing instruments, announced its third annual partnership with Quota International,s ... 2010. , As part of the renewed partnership, Siemens is ... instruments to both children and young adults, age 23 years ...
Cached Medicine Technology:MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3
Welch Allyn introduced halogen HPX lamp technology to provide 30% more light output than previous halogen lamps. The mix of halogen and xenon gases provide whiter, longer lasting light - making your ...
RT-600 Refractor...
... Ultramatic Rx Master is designed ... of reliable service and give ... measurably improve procedures. It embodies ... and want most, including accuracy, ...
Occluder and Maddox Rod...
Medicine Products: